GLP-3R 10mg

GLP-3 (Retatrutide) is a novel triple-agonist incretin research peptide currently being studied for its effects on metabolic regulation, energy balance, and glucose homeostasis. Unlike earlier incretin-based compounds that target a single receptor pathway, retatrutide is designed to simultaneously activate three key metabolic hormone receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and the Glucagon receptor. This multi-pathway mechanism has made it a significant subject of interest in metabolic and endocrinology research.

Retatrutide belongs to a class of peptides sometimes referred to as “triple incretin receptor agonists”, which aim to mimic and enhance the activity of naturally occurring hormones involved in regulating appetite, insulin secretion, glucose metabolism, and energy expenditure.

Important Disclaimer

This product is intended strictly for laboratory research purposes only.

• Not for human consumption

• Not for medical, veterinary, or diagnostic use

• Not intended to diagnose, treat, cure, or prevent any disease

• Must be handled only by qualified professionals in controlled research settings

By purchasing this product, the buyer agrees that the material will be used solely for legal scientific research purposes.